Stay updated on Talazoparib in BRCA+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Talazoparib in BRCA+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talazoparib in BRCA+ Breast Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.3 in the footer, replacing the previous Revision: v3.5.2. This indicates a software update to the page rather than a change to study details or content.
    Difference
    0.0%
    Check dated 2026-04-29T08:57:11.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page revision label was updated from **v3.5.0** to **v3.5.2**.
    Difference
    0.0%
    Check dated 2026-04-22T03:26:16.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-24T06:36:15.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3. The change appears to be a version bump with no visible modification to study details in the screenshot.
    Difference
    0.0%
    Check dated 2026-03-08T23:43:09.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    No additions or deletions detected; the page content appears unchanged between the two screenshots.
    Difference
    0.0%
    Check dated 2026-03-01T23:19:59.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 in the page footer.
    Difference
    0.0%
    Check dated 2026-02-15T14:56:44.000Z thumbnail image

Stay in the know with updates to Talazoparib in BRCA+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talazoparib in BRCA+ Breast Cancer Clinical Trial page.